By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


RetroSense Therapeutics 

2725 S. Industrial Highway, Suite 200

Ann Arbor  Michigan  48104  U.S.A.
Phone: 248-924-3298 Fax:



Gene Therapy

Company News
RetroSense Therapeutics To Present At 7th Annual Biotech Showcase Conference 1/12/2015 10:38:34 AM
RetroSense Therapeutics Raises $6 Million In Series A Financing To Further Develop Lead Product RST-001 For Retinitis Pigmentosa 1/8/2015 10:40:48 AM
RetroSense Therapeutics Receives Second "Top Project To Watch" Nomination 11/20/2014 1:54:52 PM
RetroSense Therapeutics Signs License Agreement With Massachusetts General Hospital, Expanding Its Optogenetics Intellectual Property Portfolio 11/17/2014 12:32:31 PM
RetroSense Therapeutics Granted Orphan Drug Designation For Lead Product RST-001 For Retinitis Pigmentosa 10/30/2014 11:20:51 AM
RetroSense Therapeutics Selected by Windhover Information Inc. as a "Top Project to Watch: Most Licensable Product" 10/29/2013 10:01:48 AM
RetroSense Therapeutics Announces Exclusive Option to Intellectual Property Covering Vision Augmentation From Massachusetts General Hospital 3/27/2013 10:53:53 AM
RetroSense Therapeutics Announces Notice of Allowance for New U.S. Patent Application Broadly Covering Optogenetic Approaches to Vision Restoration 3/5/2013 9:31:22 AM
RetroSense Therapeutics Welcomes Dr. Steven Bramer as Chief Development Officer 10/4/2012 10:19:18 AM
RetroSense Therapeutics Completes pre-IND Meeting for RST-001 5/24/2012 10:15:50 AM